A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, HPLC of Formula: C10H24N2, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 4062-60-6, Name is N1,N2-Di-tert-butylethane-1,2-diamine, molecular formula is C10H24N2. In a Patent, authors is ，once mentioned of 4062-60-6
This invention relates to benzodiazepine derivatives, compositions comprising therapeutically effective amounts of those derivatives and methods of using those derivatives or compositions in treating cognitive impairment associated with CNS disorders. It also relates to the use of an alpha5-containing GABAA receptor agonist (e.g., an alpha5-containing GABAA receptor positive allosteric modulator) in treating cognitive impairment associated with CNS disorders in a subject in need or at risk thereof, including age-related cognitive impairment, Mild Cognitive Impairment (MCI), amnestic MCI, Age-Associated Memory Impairment, Age Related Cognitive Decline, dementia, Alzheimer’s Disease(AD), prodromal AD, PTSD, schizophrenia, bipolar disorder, ALS, cancer-therapy-related cognitive impairment, mental retardation, Parkinson’s disease, autism spectrum disorders, fragile X disorder, Rett syndrome, compulsive behavior, and substance addiction. It also relates to the use of an alpha5-containing GABAA receptor agonist (e.g., an alpha5-containing GABAA receptor positive allosteric modulator) in treating brain cancers (including brain tumors, e.g., medulloblastomas), and cognitive impairment associated therewith.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 4062-60-6, help many people in the next few years.HPLC of Formula: C10H24N2
Reference：
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI